Skip to main content
Clinical Trials/NCT05983731
NCT05983731
Not yet recruiting
Not Applicable

A Pilot Observational Study to Assess the Ability of Continuous 'Home' EEG to Accurately Diagnose Narcolepsy and Demonstrate Response to Treatment

Guy's and St Thomas' NHS Foundation Trust0 sites60 target enrollmentSeptember 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Narcolepsy Type 1
Sponsor
Guy's and St Thomas' NHS Foundation Trust
Enrollment
60
Primary Endpoint
Sensitivity of diagnosis of Narcolepsy Type 1 derived by Dreem Headband compared to standard ICSD-3 protocol
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

The goal of this pilot observational study is to assess the ability of continuous 'home' EEG to accurately diagnose Narcolepsy in children and young people with hypersomnia. The main question[s]it aims to answer are:

  • can ambulatory home monitoring using a Dreem headband with a 'life as usual' unrestricted protocol allow accurate diagnosis of Narcolepsy, compared to gold standard in-patient PSG and MSLT
  • which EEG derived sleep parameters and study duration yield most diagnostic accuracy

Participants undergoing investigation for hypersomnia will additionally be asked to wear a Dream Headband at night for weeknights, then continuously for 48 hours over the weekend. The data from the headband will then be analysed to see if it can predict the results of the polysomnography and MSLT that form routine clinical care.

Registry
clinicaltrials.gov
Start Date
September 2023
End Date
August 2025
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participants already under investigation within GSTT children and adult sleep service for hypersomnolence
  • Age 12 to 25 years of age at recruitment
  • Participants able to understand patient information (information including DH instructions written only in English for this initial observational study) and who can provide written informed consent or assent.

Exclusion Criteria

  • Any physician diagnosed sleep disorder (e.g. sleep apnea)
  • Any physician diagnosed medical or psychiatric disorder that could explain their excessive daytime sleepiness
  • Regular use of either prescribed or recreational medication that affects sleep
  • Participation in another concurrent research study

Outcomes

Primary Outcomes

Sensitivity of diagnosis of Narcolepsy Type 1 derived by Dreem Headband compared to standard ICSD-3 protocol

Time Frame: 2 years

Sensitivity (%) of Dreem headband derived EEG in predicting a final diagnosis of Narcolepsy derived from gold standard in-patient clinical testing with polysomnography and multiple sleep latency test ICSD-3 protocol.

Negative predictive value of diagnosis of Narcolepsy Type 1 derived by Dreem Headband compared to standard ICSD-3 protocol

Time Frame: 2 years

Negative predictive value (%) of Dreem headband derived EEG in predicting a final diagnosis of Narcolepsy derived from gold standard in-patient clinical testing with polysomnography and multiple sleep latency test ICSD-3 protocol.

Positive predictive value of diagnosis of Narcolepsy Type 1 derived by Dreem Headband compared to standard ICSD-3 protocol

Time Frame: 2 years

Positive predictive value (%) of Dreem headband derived EEG in predicting a final diagnosis of Narcolepsy derived from gold standard in-patient clinical testing with polysomnography and multiple sleep latency test ICSD-3 protocol.

Specificity of diagnosis of Narcolepsy Type 1 derived by Dreem Headband compared to standard ICSD-3 protocol

Time Frame: 2 years

Specificity (%) of Dreem headband derived EEG in predicting a final diagnosis of Narcolepsy derived from gold standard in-patient clinical testing with polysomnography and multiple sleep latency test ICSD-3 protocol.

Similar Trials